Damjan Osredkar
Damjan Osredkar is the head of the Clinical Department of Pediatric, Adolescent, and Developmental Neurology at the Pediatric Clinic in Ljubljana, Slovenia. He is leading the GAIN-CTNNB1 clinical study, which aims to evaluate the safety and efficacy of the world's first gene therapy for CTNNB1 syndrome, marking a significant milestone in Slovenian medicine.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovenia:
Damjan Osredkar is the head of the clinical department for pediatric, adolescent, and developmental neurology at the pediatric clinic.
8